Towa Pharmaceutical Co(DE:6QC)
€18.90+0.10 (+0.53%)
DE:6QC
Towa Pharmaceutical Co earnings date
€18.90
At close:+0.10 (+0.53%)
Towa Pharmaceutical Co (6QC) Q2 2026 Earnings Report
0 Followers
DE:6QC Q2 2026 EPS Results
- Actual EPS
- EUR 0.15
- Consensus EPS
- EUR 0.58
- Beat/Miss
- Missed by -EUR 0.43
- One Year Ago EPS
- EUR 0.66
DE:6QC Q2 2026 Revenue Results
- Actual Revenue
- EUR 404.31M
- Expected Revenue
- EUR 404.47M
- Beat/Miss
- Missed by -EUR 161.63K
- YoY Revenue Growth
- +8.49%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/11/2026
- Time
- TBA
- Conference Call
- Wednesday, November 11, 2026
DE:6QC Upcoming Earnings
Towa Pharmaceutical Co's next earnings date is estimated for February 15, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6QC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 15, 2027 | 2026 (Q3) | 0.88- | 1.03 | ― | ― |
| Nov 11, 2026 | 2026 (Q2) | 0.580.15 | 0.66 | -77.89% (-0.51) | |
| Aug 06, 2026 | 2026 (Q1) | ―0.64 | 0.29 | 120.05% (+0.35) | |
| May 14, 2026 | 2025 (Q4) | 0.62-1.37 | 0.51 | -371.24% (-1.88) | |
| Feb 13, 2026 | 2025 (Q3) | ―1.03 | 0.94 | 9.89% (+0.09) | |
| Nov 10, 2025 | 2025 (Q2) | 0.350.66 | 0.12 | 437.85% (+0.54) | |
| Aug 07, 2025 | 2025 (Q1) | 0.360.29 | 0.64 | -54.26% (-0.35) | |
| May 15, 2025 | 2024 (Q4) | 0.650.51 | -0.08 | 702.22% (+0.59) | |
| Feb 13, 2025 | 2024 (Q3) | 0.330.94 | 0.53 | 76.71% (+0.41) | |
| Nov 12, 2024 | 2024 (Q2) | 0.280.12 | 0.26 | -51.89% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


